396 related articles for article (PubMed ID: 21837680)
61. Young age influences treatment but not outcome of colon cancer.
Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
[TBL] [Abstract][Full Text] [Related]
62. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
Ann Surg Oncol; 2006 Jun; 13(6):836-42. PubMed ID: 16604474
[TBL] [Abstract][Full Text] [Related]
63. Lymph node ratio: role in the staging of node-positive colon cancer.
Wang J; Hassett JM; Dayton MT; Kulaylat MN
Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
[TBL] [Abstract][Full Text] [Related]
64. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
65. Isolated tumor cells in lymph nodes are not a prognostic marker for patients with stage I and stage II colorectal cancer.
Lee MR; Hong CW; Yoon SN; Lim SB; Park KJ; Lee MJ; Kim WH; Park JG
J Surg Oncol; 2006 Jan; 93(1):13-8; discussion 18-9. PubMed ID: 16353185
[TBL] [Abstract][Full Text] [Related]
66. Effect of Lymph Node Retrieval and Ratio on the Long-Term Survival and Recurrence of Colon Cancer.
Rao A; Dadras M; Razzak MA; Ahmad K; Vijayasekar C
J Coll Physicians Surg Pak; 2016 Jun; 26(6):467-70. PubMed ID: 27353981
[TBL] [Abstract][Full Text] [Related]
67. Survival impact of lymph node metastasis in TNM stage III carcinoma of the colon and rectum.
Tang R; Wang JY; Chen JS; Chang-Chien CR; Tang S; Lin SE; You YT; Hsu KC; Ho YS; Fan HA
J Am Coll Surg; 1995 Jun; 180(6):705-12. PubMed ID: 7773484
[TBL] [Abstract][Full Text] [Related]
68. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
Bowne WB; Lee B; Wong WD; Ben-Porat L; Shia J; Cohen AM; Enker WE; Guillem JG; Paty PB; Weiser MR
Dis Colon Rectum; 2005 May; 48(5):897-909. PubMed ID: 15785892
[TBL] [Abstract][Full Text] [Related]
69. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
[TBL] [Abstract][Full Text] [Related]
70. Prognostic value of quantitative reverse transcription-polymerase chain reaction in lymph node-negative esophageal cancer patients.
Godfrey TE; Raja S; Finkelstein SD; Gooding WE; Kelly LA; Luketich JD
Clin Cancer Res; 2001 Dec; 7(12):4041-8. PubMed ID: 11751499
[TBL] [Abstract][Full Text] [Related]
71. T4N0 colon cancer has oncologic outcomes comparable to stage III in a specialized center.
Rottoli M; Stocchi L; Dietz DW
Ann Surg Oncol; 2012 Aug; 19(8):2500-5. PubMed ID: 22395999
[TBL] [Abstract][Full Text] [Related]
72. Estimation of the number of metastatic lymph nodes in dukes' C colorectal cancer.
Fukushima T; Akagi Y; Murakami H; Ushijima M; Ogata Y; Shirouzu K; Murotani K
Anticancer Res; 2013 Jul; 33(7):2949-55. PubMed ID: 23780985
[TBL] [Abstract][Full Text] [Related]
73. The metastatic lymph node ratio predicts survival in colon cancer.
Schumacher P; Dineen S; Barnett C; Fleming J; Anthony T
Am J Surg; 2007 Dec; 194(6):827-31; discussion 831-2. PubMed ID: 18005779
[TBL] [Abstract][Full Text] [Related]
74. The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer.
Al Sahaf O; Myers E; Jawad M; Browne TJ; Winter DC; Redmond HP
Dis Colon Rectum; 2011 Aug; 54(8):982-8. PubMed ID: 21730787
[TBL] [Abstract][Full Text] [Related]
75. Recurrence in early gastric cancer--presence of micrometastasis in lymph node of node negative early gastric cancer patient with recurrence.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
Hepatogastroenterology; 2007 Mar; 54(74):620-4. PubMed ID: 17523336
[TBL] [Abstract][Full Text] [Related]
76. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
77. Oncologic Outcomes of Colon Cancer Patients with Extraregional Lymph Node Metastasis: Comparison of Isolated Paraaortic Lymph Node Metastasis with Resectable Liver Metastasis.
Bae SU; Han YD; Cho MS; Hur H; Min BS; Baik SH; Lee KY; Kim NK
Ann Surg Oncol; 2016 May; 23(5):1562-8. PubMed ID: 26714940
[TBL] [Abstract][Full Text] [Related]
78. Prediction of survival period for patients with postoperative recurrence after curative resection for advanced gastric carcinoma.
Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(37):290-3. PubMed ID: 11268988
[TBL] [Abstract][Full Text] [Related]
79. Lymphadenectomy for adenocarcinoma of the gastroesophageal junction (GEJ): impact of adequate staging on outcome.
Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
Ann Surg Oncol; 2007 Feb; 14(2):306-16. PubMed ID: 17091329
[TBL] [Abstract][Full Text] [Related]
80. The ratio of metastatic to examined lymph nodes is a powerful independent prognostic factor in rectal cancer.
Peschaud F; Benoist S; Julié C; Beauchet A; Penna C; Rougier P; Nordlinger B
Ann Surg; 2008 Dec; 248(6):1067-73. PubMed ID: 19092352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
